These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12058747)

  • 21. Fusion of XC rat sarcoma cells induced by murine leukaemia virus-infected mouse mammary tumour cells. Absence of interference by simultaneously synthesized mammary tumour virus.
    Svec J; Links J
    Neoplasma; 1973; 20(6):699-703. PubMed ID: 4359242
    [No Abstract]   [Full Text] [Related]  

  • 22. Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
    Barnes RD; Tuffrey M; Holliday J; Hilgers JH; Souissi T
    Br J Cancer; 1976 Jul; 34(1):28-38. PubMed ID: 182191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid in vivo assay for murine lymphatic leukaemia viruses.
    Decleve A; Lieberman M; Niwa O; Kaplan HS
    Nature; 1974 Nov; 252(5478):79-81. PubMed ID: 4372542
    [No Abstract]   [Full Text] [Related]  

  • 24. Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains.
    Levy JA
    Science; 1973 Dec; 182(4117):1151-3. PubMed ID: 4356281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological Characterization of C-type retroviruses endogenous to the C57BL/6 mouse and isolated in tumours induced by radiation leukaemia virus (RadLV-Rs).
    Astier T; Guillemain B; Laigret F; Mamoun R; Duplan JF
    J Gen Virol; 1982 Jul; 61 (Pt l)():55-63. PubMed ID: 6181187
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-mediated immunity to antigens associated with endogenous murine C-type leukemia viruses.
    Hirsch ME; Kelly AP; Proffitt MR; Black PH
    Science; 1975 Mar; 187(4180):959-61. PubMed ID: 167435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of infection and neutralization of murine leukaemia virus by a microtitre enzyme-linked immunosorbent assay.
    Bayer H; Hunsmann G
    J Gen Virol; 1986 May; 67 ( Pt 5)():953-6. PubMed ID: 3009694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A glycoprotein specified by spleen focus-forming virus in three cell lines varies on molecular size and peptide composition, but retains both xenotropic and ecotropic MuLV antigenicity.
    Yoshida M; Yoshikura H
    J Gen Virol; 1981 Jan; 52(Pt 1):183-8. PubMed ID: 6267174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure to detect murine leukemia virus antigens in immune-complex glomerulonephritis of graft-vs-host F1 mice.
    Kimura M; Shimada K; Yoshiki T
    Jpn J Exp Med; 1985 Oct; 55(5):211-2. PubMed ID: 3009932
    [No Abstract]   [Full Text] [Related]  

  • 31. Radioimmunoassay of mammalian type C viral proteins. 3. Detection of viral antigen in normal murine cells and tissues.
    Parks WP; Livingston DM; Todaro GJ; Benveniste RE; Scolnick EM
    J Exp Med; 1973 Mar; 137(3):622-35. PubMed ID: 4347595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shared viral antigen of mammalian leukaemia viruses.
    Geering G; Aoki T; Old LJ
    Nature; 1970 Apr; 226(5242):265-6. PubMed ID: 4314416
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the biological and antigenic properties of ESP-1 type C virus particles.
    Eckner RJ; Priori ES; Mirand EA; Dmochowski L
    Cancer Res; 1974 Oct; 34(10):2521-9. PubMed ID: 4137948
    [No Abstract]   [Full Text] [Related]  

  • 34. Autogenous immunity to endogenous RNA tumor virus: virion and virus-induced cell surface antigens.
    Longstreth JD; Ihle JN; Hanna MG
    Ann N Y Acad Sci; 1976; 276():343-57. PubMed ID: 68698
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of the bone marrow cell population expressing an AKR murine leukaemia-virus gp71-like antigen.
    Rubio N
    Immunology; 1981 Oct; 44(2):339-45. PubMed ID: 6271666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host-gene control of C-type RNA tumor virus: inheritance of the group-specific antigen of murine leukemia virus.
    Taylor BA; Meier H; Myers DD
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3190-4. PubMed ID: 4332013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Group-specific antigens of RNA tumor viruses as markers for subinfectious expression of the RNA virus genome.
    Gilden RV; Oroszlan S
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):1021-5. PubMed ID: 4112640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of virus structural proteins on murine cell surfaces in association with the production of murine leukaemia virus.
    O'Brien SJ; Simonson JM; Boone CW
    J Gen Virol; 1976 Nov; 33(2):355-60. PubMed ID: 62822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure to detect, in human sera, antibodies cross-reactive with group-specific antigens of murine leukemia virus.
    Charman HP; Kim N; White M; Gilden RV
    J Natl Cancer Inst; 1974 May; 52(5):1409-13. PubMed ID: 4364729
    [No Abstract]   [Full Text] [Related]  

  • 40. Antigenic properties and molecular weights of murine leukemia virus-binding proteins.
    Baird SM
    J Immunol; 1979 Apr; 122(4):1389-96. PubMed ID: 221574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.